O	O	O	0	12	Differential	Differential	B-NP	JJ	O	2	NMOD	O
O	O	O	13	27	autoregulation	autoregulation	I-NP	NN	O	0	ROOT	O
O	O	O	28	30	of	of	B-PP	IN	O	2	NMOD	O
T1	B-Protein	B-Protein	31	45	glucocorticoid	glucocorticoid	B-NP	NN	B-protein	6	NMOD	B-protein
T1	I-Protein	I-Protein	46	54	receptor	receptor	I-NP	NN	I-protein	6	NMOD	I-protein
O	O	O	55	65	expression	expression	I-NP	NN	O	3	PMOD	O
O	O	O	66	68	in	in	B-PP	IN	O	6	NMOD	O
O	O	O	69	74	human	human	B-NP	JJ	B-cell_line	15	NMOD	B-cell_line
O	O	O	75	76	T	T	I-NP	NN	I-cell_line	12	NMOD	I-cell_line
O	O	O	76	77	-	-	I-NP	HYPH	I-cell_line	9	AMOD	I-cell_line
O	O	O	78	81	and	and	I-NP	CC	I-cell_line	12	NMOD	I-cell_line
O	O	O	82	83	B	B	I-NP	NN	I-cell_line	15	NMOD	I-cell_line
O	O	O	83	84	-	-	B-NP	HYPH	I-cell_line	15	NMOD	I-cell_line
O	O	O	84	88	cell	cell	I-NP	NN	I-cell_line	15	NMOD	I-cell_line
O	O	O	89	94	lines	line	I-NP	NNS	I-cell_line	7	PMOD	I-cell_line
O	O	O	94	95	.	.	O	.	O	2	P	O

O	O	O	97	107	Regulation	Regulation	B-NP	NN	O	13	SUB	O
O	O	O	108	110	of	of	B-PP	IN	O	1	NMOD	O
T2	B-Protein	B-Protein	111	125	glucocorticoid	glucocorticoid	B-NP	NN	B-protein	4	NMOD	B-protein
T2	I-Protein	I-Protein	126	134	receptor	receptor	I-NP	NN	I-protein	8	NMOD	I-protein
O	O	O	135	136	(	(	O	(	O	7	DEP	O
T3	B-Protein	B-Protein	136	138	GR	GR	B-NP	NN	B-protein	7	DEP	B-protein
O	O	O	138	139	)	)	O	)	O	4	NMOD	O
O	O	O	140	150	expression	expression	B-NP	NN	O	2	PMOD	O
O	O	O	151	153	by	by	B-PP	IN	O	1	NMOD	O
O	O	O	154	157	its	its	B-NP	PRP$	O	12	NMOD	O
O	O	O	158	165	cognate	cognate	I-NP	JJ	O	12	NMOD	O
O	O	O	166	172	ligand	ligand	I-NP	NN	O	9	PMOD	O
O	O	O	173	176	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	177	185	examined	examine	I-VP	VBN	O	13	VC	O
O	O	O	186	188	in	in	B-PP	IN	O	14	VMOD	O
O	O	O	189	192	the	the	B-NP	DT	O	26	NMOD	O
O	O	O	193	207	glucocorticoid	glucocorticoid	I-NP	NN	B-cell_line	25	NMOD	B-cell_line
O	O	O	207	208	-	-	B-NP	HYPH	I-cell_line	25	P	I-cell_line
O	O	O	208	217	sensitive	sensitive	I-NP	JJ	I-cell_line	25	NMOD	I-cell_line
O	O	O	218	223	human	human	I-NP	JJ	I-cell_line	25	NMOD	I-cell_line
O	O	O	224	232	leukemic	leukemic	I-NP	JJ	I-cell_line	25	NMOD	I-cell_line
O	O	O	233	234	T	T	I-NP	NN	I-cell_line	25	NMOD	I-cell_line
O	O	O	234	235	-	-	I-NP	HYPH	I-cell_line	25	NMOD	I-cell_line
O	O	O	235	239	cell	cell	I-NP	NN	I-cell_line	25	NMOD	I-cell_line
O	O	O	240	244	line	line	I-NP	NN	I-cell_line	26	NMOD	I-cell_line
O	O	O	245	249	6TG1	6TG1	I-NP	NN	O	15	PMOD	O
O	O	O	249	250	.	.	O	.	O	13	P	O
O	O	O	250	251	1	1	B-NP	CD	O	13	PRD	O
O	O	O	252	255	and	and	O	CC	O	28	NMOD	O
O	O	O	256	258	in	in	B-PP	IN	O	29	PRD	O
O	O	O	259	262	the	the	B-NP	DT	O	37	NMOD	O
O	O	O	263	268	human	human	I-NP	JJ	B-cell_line	36	NMOD	B-cell_line
O	O	O	269	270	B	B	I-NP	NN	I-cell_line	36	NMOD	I-cell_line
O	O	O	270	271	-	-	B-NP	HYPH	I-cell_line	36	NMOD	I-cell_line
O	O	O	271	275	cell	cell	I-NP	NN	I-cell_line	36	NMOD	I-cell_line
O	O	O	276	280	line	line	I-NP	NN	I-cell_line	37	NMOD	I-cell_line
O	O	O	281	283	IM	IM	I-NP	NN	O	39	NMOD	O
O	O	O	283	284	-	-	B-NP	HYPH	O	39	P	O
O	O	O	284	285	9	9	I-NP	CD	O	30	PMOD	O
O	O	O	285	286	.	.	O	.	O	13	P	O

O	O	O	287	289	In	In	B-PP	IN	O	33	VMOD	O
O	O	O	290	298	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	O	299	301	to	to	B-PP	TO	O	2	NMOD	O
O	O	O	302	305	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	306	314	decrease	decrease	I-NP	NN	O	3	PMOD	O
O	O	O	315	317	in	in	B-PP	IN	O	5	NMOD	O
T4	B-Protein	B-Protein	318	320	GR	GR	B-NP	NN	B-RNA	8	NMOD	B-RNA
O	O	O	321	325	mRNA	mRNA	I-NP	NN	I-RNA	6	PMOD	I-RNA
O	O	O	326	330	seen	see	B-VP	VBN	O	5	NMOD	O
O	O	O	331	333	in	in	B-PP	IN	O	9	VMOD	O
O	O	O	334	336	IM	IM	B-NP	NN	B-cell_line	14	NMOD	B-cell_line
O	O	O	336	337	-	-	B-NP	HYPH	I-cell_line	14	NMOD	I-cell_line
O	O	O	337	338	9	9	I-NP	CD	I-cell_line	14	NMOD	I-cell_line
O	O	O	339	344	cells	cell	I-NP	NNS	I-cell_line	10	PMOD	I-cell_line
O	O	O	345	350	after	after	B-PP	IN	O	9	VMOD	O
O	O	O	351	360	treatment	treatment	B-NP	NN	O	15	PMOD	O
O	O	O	361	365	with	with	B-PP	IN	O	16	NMOD	O
O	O	O	366	367	1	1	B-NP	CD	O	19	AMOD	O
O	O	O	368	374	microM	microM	I-NP	NN	O	20	NMOD	O
O	O	O	375	388	dexamethasone	dexamethasone	I-NP	NN	O	17	PMOD	O
O	O	O	389	392	for	for	B-PP	IN	O	16	NMOD	O
O	O	O	393	395	16	16	B-NP	CD	O	25	NMOD	O
O	O	O	395	396	-	-	I-NP	HYPH	O	25	NMOD	O
O	O	O	396	398	18	18	I-NP	CD	O	25	NMOD	O
O	O	O	399	400	h	h	I-NP	NN	O	21	PMOD	O
O	O	O	400	401	,	,	O	,	O	33	P	O
O	O	O	402	411	treatment	treatment	B-NP	NN	O	32	NMOD	O
O	O	O	412	414	of	of	B-PP	IN	O	27	NMOD	O
O	O	O	415	419	6TG1	6TG1	B-NP	NN	B-cell_line	28	PMOD	B-cell_line
O	O	O	419	420	.	.	O	.	I-cell_line	32	NMOD	I-cell_line
O	O	O	420	421	1	1	B-NP	CD	I-cell_line	32	NMOD	I-cell_line
O	O	O	422	427	cells	cell	I-NP	NNS	I-cell_line	33	SUB	I-cell_line
O	O	O	428	436	resulted	result	B-VP	VBD	O	0	ROOT	O
O	O	O	437	439	in	in	B-PP	IN	O	33	VMOD	O
O	O	O	440	442	an	an	B-NP	DT	O	39	NMOD	O
O	O	O	443	444	8	8	I-NP	CD	O	38	AMOD	O
O	O	O	444	445	-	-	I-NP	HYPH	O	38	AMOD	O
O	O	O	445	449	fold	fold	I-NP	JJ	O	39	NMOD	O
O	O	O	450	458	increase	increase	I-NP	NN	O	34	PMOD	O
O	O	O	459	461	in	in	B-PP	IN	O	39	NMOD	O
T5	B-Protein	B-Protein	462	464	GR	GR	B-NP	NN	B-RNA	42	NMOD	B-RNA
O	O	O	465	469	mRNA	mRNA	I-NP	NN	I-RNA	40	PMOD	I-RNA
O	O	O	469	470	,	,	O	,	O	33	P	O
O	O	O	471	473	as	as	B-SBAR	IN	O	33	VMOD	O
O	O	O	474	484	determined	determine	B-VP	VBN	O	44	SBAR	O
O	O	O	485	487	by	by	B-PP	IN	O	45	VMOD	O
O	O	O	488	496	Northern	Northern	B-NP	NN	O	48	NMOD	O
O	O	O	497	501	blot	blot	I-NP	NN	O	52	NMOD	O
O	O	O	502	505	and	and	O	CC	O	52	NMOD	O
O	O	O	506	511	RNase	RNase	B-NP	NN	B-protein	52	NMOD	B-protein
O	O	O	512	522	protection	protection	I-NP	NN	O	52	NMOD	O
O	O	O	523	531	analysis	analysis	I-NP	NN	O	46	PMOD	O
O	O	O	531	532	,	,	O	,	O	33	P	O
O	O	O	533	537	with	with	B-PP	IN	O	33	VMOD	O
O	O	O	538	539	a	a	B-NP	DT	O	54	PMOD	O
O	O	O	540	553	corresponding	correspond	I-NP	VBG	O	55	NMOD	O
O	O	O	554	555	3	3	I-NP	CD	O	56	OBJ	O
O	O	O	555	556	-	-	B-ADJP	HYPH	O	57	NMOD	O
O	O	O	557	559	to	to	B-PP	TO	O	58	VMOD	O
O	O	O	560	561	4	4	B-NP	CD	O	62	AMOD	O
O	O	O	561	562	-	-	I-NP	HYPH	O	62	AMOD	O
O	O	O	562	566	fold	fold	I-NP	JJ	O	63	NMOD	O
O	O	O	567	575	increase	increase	I-NP	NN	O	59	PMOD	O
O	O	O	576	578	in	in	B-PP	IN	O	63	NMOD	O
T6	B-Protein	B-Protein	579	581	GR	GR	B-NP	NN	B-protein	66	NMOD	B-protein
O	O	O	582	589	protein	protein	I-NP	NN	I-protein	64	PMOD	I-protein
O	O	O	589	590	.	.	O	.	O	33	P	O

O	O	O	591	595	Half	Half	B-NP	NN	B-protein	4	NMOD	B-protein
O	O	O	595	596	-	-	I-NP	HYPH	O	4	NMOD	O
O	O	O	596	603	maximal	maximal	I-NP	JJ	O	4	NMOD	O
O	O	O	604	613	induction	induction	I-NP	NN	O	14	NMOD	O
O	O	O	614	616	of	of	B-PP	IN	O	4	NMOD	O
T7	B-Protein	B-Protein	617	619	GR	GR	B-NP	NN	B-RNA	5	PMOD	B-RNA
O	O	O	620	624	mRNA	mRNA	I-NP	NN	I-RNA	9	NMOD	I-RNA
O	O	O	625	628	and	and	I-NP	CC	O	9	NMOD	O
O	O	O	629	636	protein	protein	I-NP	NN	O	6	NMOD	O
O	O	O	637	639	in	in	B-PP	IN	O	4	NMOD	O
O	O	O	640	644	6TG1	6TG1	B-NP	NN	B-cell_line	10	PMOD	B-cell_line
O	O	O	644	645	.	.	O	.	I-cell_line	4	P	I-cell_line
O	O	O	645	646	1	1	B-NP	CD	I-cell_line	14	NMOD	I-cell_line
O	O	O	647	652	cells	cell	I-NP	NNS	I-cell_line	15	SUB	I-cell_line
O	O	O	653	656	was	be	B-VP	VBD	O	32	VMOD	O
O	O	O	657	665	observed	observe	I-VP	VBN	O	15	VC	O
O	O	O	666	673	between	between	B-PP	IN	O	16	VMOD	O
O	O	O	674	676	10	10	B-NP	CD	O	21	AMOD	O
O	O	O	676	677	-	-	I-NP	HYPH	O	21	AMOD	O
O	O	O	677	680	100	100	I-NP	CD	O	21	AMOD	O
O	O	O	681	683	nM	nM	I-NP	NN	O	22	NMOD	O
O	O	O	684	697	dexamethasone	dexamethasone	I-NP	NN	O	17	PMOD	O
O	O	O	697	698	,	,	O	,	O	32	P	O
O	O	O	699	702	and	and	O	CC	O	32	VMOD	O
O	O	O	703	712	inclusion	inclusion	B-NP	NN	O	32	SUB	O
O	O	O	713	715	of	of	B-PP	IN	O	25	NMOD	O
O	O	O	716	717	1	1	B-NP	CD	O	28	AMOD	O
O	O	O	718	724	microM	microM	I-NP	NN	O	29	NMOD	O
O	O	O	725	727	RU	RU	I-NP	NN	O	26	PMOD	O
O	O	O	728	733	38486	38486	I-NP	CD	O	29	NMOD	O
O	O	O	734	744	completely	completely	B-ADVP	RB	O	32	VMOD	O
O	O	O	745	752	blocked	block	B-VP	VBD	O	0	ROOT	O
O	O	O	753	756	the	the	B-NP	DT	O	34	NMOD	O
O	O	O	757	764	effects	effect	I-NP	NNS	O	32	OBJ	O
O	O	O	765	767	of	of	B-PP	IN	O	34	NMOD	O
O	O	O	768	771	100	100	B-NP	CD	O	37	AMOD	O
O	O	O	772	774	nM	nM	I-NP	NN	O	38	NMOD	O
O	O	O	775	788	dexamethasone	dexamethasone	I-NP	NN	O	35	PMOD	O
O	O	O	788	789	,	,	O	,	O	32	P	O
O	O	O	790	803	demonstrating	demonstrate	B-VP	VBG	O	32	VMOD	O
O	O	O	804	808	that	that	B-SBAR	IN	O	40	VMOD	O
O	O	O	809	817	positive	positive	B-NP	JJ	O	43	NMOD	O
O	O	O	818	832	autoregulation	autoregulation	I-NP	NN	O	52	SUB	O
O	O	O	833	835	of	of	B-PP	IN	O	43	NMOD	O
T8	B-Protein	B-Protein	836	838	GR	GR	B-NP	NN	B-protein	46	NMOD	B-protein
O	O	O	839	849	expression	expression	I-NP	NN	O	44	PMOD	O
O	O	O	850	852	in	in	B-PP	IN	O	43	NMOD	O
O	O	O	853	857	6TG1	6TG1	B-NP	NN	B-cell_line	47	PMOD	B-cell_line
O	O	O	857	858	.	.	O	.	I-cell_line	51	NMOD	I-cell_line
O	O	O	858	859	1	1	B-NP	CD	I-cell_line	51	NMOD	I-cell_line
O	O	O	860	865	cells	cell	I-NP	NNS	I-cell_line	43	NMOD	I-cell_line
O	O	O	866	868	is	be	B-VP	VBZ	O	41	SBAR	O
O	O	O	869	870	a	a	B-NP	DT	O	54	NMOD	O
O	O	O	871	879	receptor	receptor	I-NP	NN	O	57	NMOD	O
O	O	O	879	880	-	-	O	HYPH	O	57	NMOD	O
O	O	O	880	888	mediated	mediate	B-NP	VBN	O	57	NMOD	O
O	O	O	889	897	response	response	I-NP	NN	O	52	PRD	O
O	O	O	897	898	.	.	O	.	O	32	P	O

O	O	O	899	907	Positive	Positive	B-NP	JJ	O	2	NMOD	O
O	O	O	908	922	autoregulation	autoregulation	I-NP	NN	O	6	SUB	O
O	O	O	923	925	of	of	B-PP	IN	O	2	NMOD	O
T9	B-Protein	B-Protein	926	928	GR	GR	B-NP	NN	B-protein	5	NMOD	B-protein
O	O	O	929	939	expression	expression	I-NP	NN	O	3	PMOD	O
O	O	O	940	943	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	944	948	also	also	I-VP	RB	O	6	VMOD	O
O	O	O	949	957	observed	observe	I-VP	VBN	O	6	VC	O
O	O	O	958	960	in	in	B-PP	IN	O	8	VMOD	O
O	O	O	961	975	glucocorticoid	glucocorticoid	B-NP	NN	B-cell_line	16	NMOD	B-cell_line
O	O	O	975	976	-	-	O	HYPH	I-cell_line	16	NMOD	I-cell_line
O	O	O	976	985	resistant	resistant	B-NP	JJ	I-cell_line	16	NMOD	I-cell_line
O	O	O	986	989	CEM	CEM	I-NP	NN	I-cell_line	16	NMOD	I-cell_line
O	O	O	989	990	-	-	B-NP	HYPH	I-cell_line	16	NMOD	I-cell_line
O	O	O	990	992	C1	C1	I-NP	NN	I-cell_line	16	NMOD	I-cell_line
O	O	O	993	998	cells	cell	I-NP	NNS	I-cell_line	9	PMOD	I-cell_line
O	O	O	998	999	,	,	O	,	O	16	P	O
O	O	O	1000	1005	which	which	B-NP	WDT	O	16	NMOD	O
O	O	O	1006	1013	contain	contain	B-VP	VBP	O	18	SBAR	O
O	O	O	1014	1024	functional	functional	B-NP	JJ	O	21	NMOD	O
T10	B-Protein	B-Protein	1025	1027	GR	GR	I-NP	NN	B-protein	19	OBJ	B-protein
O	O	O	1027	1028	,	,	O	,	O	26	P	O
O	O	O	1029	1032	but	but	O	CC	O	26	VMOD	O
O	O	O	1033	1038	whose	whose	B-NP	WP$	O	25	NMOD	O
O	O	O	1039	1045	growth	growth	I-NP	NN	O	26	SUB	O
O	O	O	1046	1048	is	be	B-VP	VBZ	O	18	SBAR	O
O	O	O	1049	1059	unaffected	unaffected	B-ADJP	JJ	O	26	VC	O
O	O	O	1060	1062	by	by	B-PP	IN	O	27	VMOD	O
O	O	O	1063	1078	glucocorticoids	glucocorticoid	B-NP	NNS	O	28	PMOD	O
O	O	O	1078	1079	.	.	O	.	O	6	P	O

O	O	O	1080	1084	Thus	Thus	B-ADVP	RB	O	5	VMOD	O
O	O	O	1084	1085	,	,	O	,	O	5	P	O
O	O	O	1086	1094	positive	positive	B-NP	JJ	O	4	NMOD	O
O	O	O	1095	1109	autoregulation	autoregulation	I-NP	NN	O	5	SUB	O
O	O	O	1110	1112	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	1113	1120	neither	neither	O	CC	O	12	NMOD	O
O	O	O	1121	1122	a	a	B-NP	DT	O	8	NMOD	O
O	O	O	1123	1134	consequence	consequence	I-NP	NN	O	12	NMOD	O
O	O	O	1135	1138	nor	nor	O	CC	O	12	NMOD	O
O	O	O	1139	1142	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	1143	1147	sole	sole	I-NP	JJ	O	12	NMOD	O
O	O	O	1148	1153	cause	cause	I-NP	NN	O	5	PRD	O
O	O	O	1154	1156	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	1157	1163	growth	growth	B-NP	NN	O	15	NMOD	O
O	O	O	1164	1170	arrest	arrest	I-NP	NN	O	13	PMOD	O
O	O	O	1170	1171	.	.	O	.	O	5	P	O

O	O	O	1172	1175	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	1176	1182	degree	degree	I-NP	NN	O	13	NMOD	O
O	O	O	1183	1185	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	1186	1194	negative	negative	B-NP	JJ	O	5	NMOD	O
O	O	O	1195	1209	autoregulation	autoregulation	I-NP	NN	O	3	PMOD	O
O	O	O	1210	1212	in	in	B-PP	IN	O	5	NMOD	O
O	O	O	1213	1215	IM	IM	B-NP	NN	B-cell_line	10	NMOD	B-cell_line
O	O	O	1215	1216	-	-	O	HYPH	I-cell_line	10	NMOD	I-cell_line
O	O	O	1216	1217	9	9	B-NP	CD	I-cell_line	10	NMOD	I-cell_line
O	O	O	1218	1223	cells	cell	I-NP	NNS	I-cell_line	6	PMOD	I-cell_line
O	O	O	1224	1227	and	and	O	CC	O	13	NMOD	O
O	O	O	1228	1236	positive	positive	B-NP	JJ	O	13	NMOD	O
O	O	O	1237	1251	autoregulation	autoregulation	I-NP	NN	O	18	NMOD	O
O	O	O	1252	1254	in	in	B-PP	IN	O	13	NMOD	O
O	O	O	1255	1259	6TG1	6TG1	B-NP	NN	B-cell_line	14	PMOD	B-cell_line
O	O	O	1259	1260	.	.	O	.	I-cell_line	13	P	I-cell_line
O	O	O	1260	1261	1	1	B-NP	CD	I-cell_line	18	NMOD	I-cell_line
O	O	O	1262	1267	cells	cell	I-NP	NNS	I-cell_line	19	SUB	I-cell_line
O	O	O	1268	1271	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1272	1282	unaffected	unaffected	B-ADJP	JJ	O	19	VC	O
O	O	O	1283	1285	by	by	B-PP	IN	O	20	VMOD	O
O	O	O	1286	1296	inhibition	inhibition	B-NP	NN	O	21	PMOD	O
O	O	O	1297	1299	of	of	B-PP	IN	O	22	NMOD	O
O	O	O	1300	1307	protein	protein	B-NP	NN	O	25	NMOD	O
O	O	O	1308	1317	synthesis	synthesis	I-NP	NN	O	23	PMOD	O
O	O	O	1318	1322	with	with	B-PP	IN	O	25	NMOD	O
O	O	O	1323	1336	cycloheximide	cycloheximide	B-NP	NN	O	26	PMOD	O
O	O	O	1336	1337	.	.	O	.	O	19	P	O

O	O	O	1338	1349	Measurement	Measurement	B-NP	NN	O	10	NMOD	O
O	O	O	1350	1352	of	of	B-PP	IN	O	1	NMOD	O
T11	B-Protein	B-Protein	1353	1355	GR	GR	B-NP	NN	B-RNA	5	NMOD	B-RNA
O	O	O	1356	1360	mRNA	mRNA	I-NP	NN	I-RNA	5	NMOD	I-RNA
O	O	O	1361	1369	turnover	turnover	I-NP	NN	O	2	PMOD	O
O	O	O	1370	1372	in	in	B-PP	IN	O	5	NMOD	O
O	O	O	1373	1377	6TG1	6TG1	B-NP	NN	B-cell_line	6	PMOD	B-cell_line
O	O	O	1377	1378	.	.	O	.	I-cell_line	1	P	I-cell_line
O	O	O	1378	1379	1	1	B-NP	CD	I-cell_line	10	NMOD	I-cell_line
O	O	O	1380	1385	cells	cell	I-NP	NNS	I-cell_line	16	SUB	I-cell_line
O	O	O	1386	1393	treated	treat	B-VP	VBN	O	10	NMOD	O
O	O	O	1394	1398	with	with	B-PP	IN	O	11	VMOD	O
O	O	O	1399	1410	actinomycin	actinomycin	B-NP	NN	O	15	NMOD	O
O	O	O	1410	1411	-	-	I-NP	HYPH	O	15	NMOD	O
O	O	O	1411	1412	D	D	I-NP	NN	O	12	PMOD	O
O	O	O	1413	1421	revealed	reveal	B-VP	VBD	O	0	ROOT	O
O	O	O	1422	1423	a	a	B-NP	DT	O	20	NMOD	O
O	O	O	1424	1428	half	half	I-NP	JJ	O	20	NMOD	O
O	O	O	1428	1429	-	-	I-NP	HYPH	O	20	NMOD	O
O	O	O	1429	1433	life	life	I-NP	NN	O	16	OBJ	O
O	O	O	1434	1436	of	of	B-PP	IN	O	20	NMOD	O
O	O	O	1437	1438	2	2	B-NP	CD	O	25	NMOD	O
O	O	O	1438	1439	.	.	O	.	O	22	P	O
O	O	O	1439	1440	5	5	B-NP	CD	O	25	NMOD	O
O	O	O	1441	1442	h	h	I-NP	NN	O	21	PMOD	O
O	O	O	1442	1443	,	,	O	,	O	20	P	O
O	O	O	1444	1449	which	which	B-NP	WDT	O	20	NMOD	O
O	O	O	1450	1453	was	be	B-VP	VBD	O	27	SBAR	O
O	O	O	1454	1464	unaffected	unaffected	B-ADJP	JJ	O	28	VC	O
O	O	O	1465	1467	by	by	B-PP	IN	O	29	VMOD	O
O	O	O	1468	1481	dexamethasone	dexamethasone	B-NP	NN	O	32	NMOD	O
O	O	O	1482	1491	treatment	treatment	I-NP	NN	O	30	PMOD	O
O	O	O	1491	1492	.	.	O	.	O	16	P	O

O	O	O	1493	1494	A	A	B-NP	DT	O	5	NMOD	O
O	O	O	1495	1502	similar	similar	I-NP	JJ	O	5	NMOD	O
O	O	O	1503	1507	half	half	I-NP	NN	O	5	NMOD	O
O	O	O	1507	1508	-	-	I-NP	HYPH	O	5	NMOD	O
O	O	O	1508	1512	life	life	I-NP	NN	O	6	SUB	O
O	O	O	1513	1516	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1517	1527	determined	determine	I-VP	VBN	O	6	VC	O
O	O	O	1528	1530	in	in	B-PP	IN	O	7	VMOD	O
O	O	O	1531	1533	IM	IM	B-NP	NN	B-cell_line	12	NMOD	B-cell_line
O	O	O	1533	1534	-	-	O	HYPH	I-cell_line	12	NMOD	I-cell_line
O	O	O	1534	1535	9	9	B-NP	CD	I-cell_line	12	NMOD	I-cell_line
O	O	O	1536	1541	cells	cell	I-NP	NNS	I-cell_line	8	PMOD	I-cell_line
O	O	O	1542	1545	and	and	O	CC	O	6	VMOD	O
O	O	O	1546	1549	was	be	B-VP	VBD	O	6	VMOD	O
O	O	O	1550	1554	also	also	B-ADVP	RB	O	14	VMOD	O
O	O	O	1555	1565	unaffected	unaffected	B-ADJP	JJ	O	14	VC	O
O	O	O	1566	1568	by	by	B-PP	IN	O	16	VMOD	O
O	O	O	1569	1576	steroid	steroid	B-NP	NN	O	19	NMOD	O
O	O	O	1577	1586	treatment	treatment	I-NP	NN	O	17	PMOD	O
O	O	O	1586	1587	.	.	O	.	O	6	P	O

O	O	O	1588	1593	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1594	1601	results	result	I-NP	NNS	O	3	SUB	O
O	O	O	1602	1605	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	1606	1616	consistent	consistent	B-ADJP	JJ	O	3	PRD	O
O	O	O	1617	1621	with	with	B-PP	IN	O	4	AMOD	O
O	O	O	1622	1625	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	1626	1640	interpretation	interpretation	I-NP	NN	O	5	PMOD	O
O	O	O	1641	1645	that	that	B-SBAR	IN	O	7	NMOD	O
O	O	O	1646	1660	glucocorticoid	glucocorticoid	B-NP	NN	O	16	SUB	O
O	O	O	1660	1661	-	-	B-VP	HYPH	O	9	NMOD	O
O	O	O	1661	1669	mediated	mediate	B-NP	VBN	O	12	NMOD	O
O	O	O	1670	1684	autoregulation	autoregulation	I-NP	NN	O	10	OBJ	O
O	O	O	1685	1687	of	of	B-PP	IN	O	12	NMOD	O
T12	B-Protein	B-Protein	1688	1690	GR	GR	B-NP	NN	B-protein	15	NMOD	B-protein
O	O	O	1691	1701	expression	expression	I-NP	NN	O	13	PMOD	O
O	O	O	1702	1704	is	be	B-VP	VBZ	O	8	SBAR	O
O	O	O	1705	1706	a	a	B-NP	DT	O	18	NMOD	O
O	O	O	1707	1713	tissue	tissue	I-NP	NN	O	23	NMOD	O
O	O	O	1713	1714	-	-	B-NP	HYPH	O	23	NMOD	O
O	O	O	1714	1722	specific	specific	I-NP	JJ	O	23	NMOD	O
O	O	O	1723	1730	primary	primary	I-NP	JJ	O	23	NMOD	O
O	O	O	1731	1746	transcriptional	transcriptional	I-NP	JJ	O	23	NMOD	O
O	O	O	1747	1755	response	response	I-NP	NN	O	16	PRD	O
O	O	O	1755	1756	.	.	O	.	O	3	P	O
